Inspire Medical Systems Inc Asset Resilience Ratio
Inspire Medical Systems Inc asset resilience ratio. Inspire Medical Systems Inc (INSP) has an Asset Resilience Ratio of 20.83% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See INSP cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Inspire Medical Systems Inc (2016–2025)
Asset resilience ratio of Inspire Medical Systems Inc from 2016 to 2025. This chart shows how Inspire Medical Systems Inc's Asset Resilience Ratio has changed over time. Read INSP total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Inspire Medical Systems Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Inspire Medical Systems Inc.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $192.92 Million | 20.83% |
| Total Liquid Assets | $192.92 Million | 20.83% |
Asset Resilience Insights
- Good Liquidity Position: Inspire Medical Systems Inc maintains a healthy 20.83% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Inspire Medical Systems Inc Industry Peers by Asset Resilience Ratio
Compare Inspire Medical Systems Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085 |
Medical Devices | 7.69% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
Inspire Medical Systems Inc Asset Resilience Ratio by Year (2016–2025)
Inspire Medical Systems Inc asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for Inspire Medical Systems Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 22.42% | $203.46 Million | $907.32 Million | -14.12pp |
| 2024-12-31 | 36.54% | $295.40 Million | $808.38 Million | -4.07pp |
| 2023-12-31 | 40.61% | $274.84 Million | $676.81 Million | +38.87pp |
| 2022-12-31 | 1.74% | $9.82 Million | $564.88 Million | -- |
| 2021-12-31 | 0.00% | $0.00 | $295.08 Million | -- |
| 2020-12-31 | 15.59% | $43.84 Million | $281.19 Million | -54.26pp |
| 2019-12-31 | 69.85% | $126.61 Million | $181.25 Million | +24.41pp |
| 2018-12-31 | 45.44% | $90.92 Million | $200.08 Million | +16.80pp |
| 2017-12-31 | 28.65% | $7.19 Million | $25.09 Million | -- |
| 2016-12-31 | 0.00% | $0.00 | $13.12 Million | -- |
About Inspire Medical Systems Inc
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develop… Read more